These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 13801696)

  • 1. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():349-57. PubMed ID: 13801696
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on cytolysis of Ehrlich ascites tumor cells brought into contact with normal human serum. The nature of the heat-labile factor.
    TOKUNAGA A; OKAMURA J; KOSAKI G; KURU M
    Gan; 1962 Jun; 53():145-58. PubMed ID: 13921595
    [No Abstract]   [Full Text] [Related]  

  • 3. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.
    PENSKY J; WURZ L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():329-48. PubMed ID: 14431638
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 6. The properdin system and immunity. V. The bactericidal activity of the properdin system.
    WARDLAW AC; PILLEMER L
    J Exp Med; 1956 May; 103(5):553-75. PubMed ID: 13319578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 8. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The properdin system and immunity. IX. Studies on the purification of human properdin.
    TODD EW; PILLEMER L; LEPOW IH
    J Immunol; 1959 Oct; 83():418-27. PubMed ID: 13838615
    [No Abstract]   [Full Text] [Related]  

  • 10. The properdin system and immunity. X. Characterization of partially purified human properdin.
    LEPOW IH; PILLEMER L; SCHOENBERG MD; TODD EW; WEDGWOOD RJ
    J Immunol; 1959 Oct; 83():428-36. PubMed ID: 14415902
    [No Abstract]   [Full Text] [Related]  

  • 11. [The properdin system. Part 1. A modified method for determination of properdin in the serum].
    MAASSEN W
    Z Immun exp ther; 1960 May; 119():405-14. PubMed ID: 14419242
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the interaction of properdin with the complement of human sera].
    BIANCHI V; GHIRARDO G; SANGUINETI M
    Minerva Med; 1959 Jul; 50():2358-61. PubMed ID: 13800410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Properdin and complement in metabolism of the lung].
    SCHABINSKI G; WILDE J
    Klin Wochenschr; 1961 May; 39():477-81. PubMed ID: 13747130
    [No Abstract]   [Full Text] [Related]  

  • 14. The concentration of component A in blood, its assay and relation to the labile factor.
    QUICK AJ; STEFANINI M
    J Lab Clin Med; 1949 Jul; 34(7):973-82. PubMed ID: 18133827
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial properdin deficiency.
    Davis CA; Forristal J
    J Lab Clin Med; 1980 Oct; 96(4):633-9. PubMed ID: 6903190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in natural immunity and the content of vitamin B12 in patients with leukosis in relation to treatment].
    AKKERMAN VV; IVANOVA NM; KLIMOVA KN; KROTOVA TA; MIASISHCHEVA NV
    Probl Gematol Pereliv Krovi; 1962 Jun; 7():3-11. PubMed ID: 13859957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunochemical studies on the mechanism of allergic diseases. II. The complement and properdin titer of sensitized and anaphylactic shock-exposed guinea pigs].
    DRESSLER O
    Z Immun exp ther; 1959 Sep; 118():175-80. PubMed ID: 13818067
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the study of the properdin system. I. A simplified method for the determination of properdin].
    ROZENTAL' KM ; SAVEL'VOL'F GB
    Biull Eksp Biol Med; 1959 Nov; 48():122-6. PubMed ID: 13856311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quartz dust and resistance. Properdin titer and serum bactericidal properties of rats under the influence of inhaled dust].
    FRITZE E; PILTZ I; von VOIGT
    Z Gesamte Exp Med; 1961; 134():400-6. PubMed ID: 13702166
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
    Ruley EJ; Forristal J; Davis NC; Andres C; West CD
    J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.